Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Corticosteroid 11-beta-dehydrogenase isozyme 1 (11β-HSD1) is an NADPH-dependent enzyme that catalyzes the reversible conversion of inactive cortisone to active cortisol. It is highly expressed in metabolic tissues including the liver, adipose tissue, and central nervous system. By regenerating active cortisol within tissues, it amplifies local glucocorticoid action independently of circulating hormone levels. Overactivity or dysregulation has been implicated in obesity-related complications and cognitive symptoms linked with stress axis overactivation.
Inhibition of cortisone to cortisol conversion
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corticosteroid 11-beta-dehydrogenase isozyme 1 (11β-HSD1).